Innovation and Management of
Diabetic Foot Wounds
Mark W. Clemens, MD
Clinical Specialist and Microsurgery Fellow, Department of Plastic Surgery
MD Anderson Cancer Center
University of Texas
Houston, TX
Justin M. Broyles, BS
Medical Student
The University of Texas Medical School at Houston
Houston, TX
Phi-Nga Jeannie Le, MD
Director, Undersea and Hyperbaric Medicine
Georgetown University Hospital
Washington, DC
Christopher E. Attinger, MD
Director, Wound Healing Center
Professor of Surgery, Department of Plastic Surgery
Georgetown University Medical Center
Washington, DC
Recent innovations in the field of wound healing have created numerous advanced therapies from which clinicians may now choose. The challenge for the reconstructive surgeon is to ensure that these adjunct technologies are used according to an evidence-based protocol to ensure optimal healing. Critical to successful outcomes is that new modes of therapy do not supplant, but are used in tandem with, core principles of wound management: establishing a correct diagnosis, ensuring a good local blood supply, debriding the wound to a clean base, correcting the biomechanical abnormality, and nurturing the wound until it shows signs of healing. Debridement should be performed as often as necessary until the wound is deemed clean and ready for reconstruction. Useful adjuncts in debridement include hydrotherapy and ultrasonic therapy. The majority of reconstructions are accomplished through simple techniques. If a wound is not meeting the expected healing trajectory, management adjuncts such as negative pressure wound therapy, growth factor, cultured skin, and hyperbaric oxygen can then reactivate or expedite the process toward achieving a healed wound.